Earnings Labs
EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc. (EYPT) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$13.45

-1.10%

Mkt Cap $1.15B

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 4, 2026

$994.46K$620.00K-37.65%-$0.78-$0.81-3.85%
Q4 2025

Nov 5, 2025

$1.01M$966.00K-3.96%-$0.77-$0.85-10.39%
Q3 2025

Aug 6, 2025

$4.13M$5.33M+29.22%-$0.67-$0.85-26.87%
Q2 2025

May 7, 2025

$6.82M$24.45M+258.36%-$0.65-$0.65+0.00%
Q1 2025

Mar 5, 2025

$8.19M$11.59M+41.54%-$0.54-$0.64-18.52%
Q4 2024

Nov 7, 2024

$10.56M$10.52M-0.34%-$0.48-$0.54-12.50%
Q3 2024

Aug 7, 2024

$9.59M$9.48M-1.18%-$0.55-$0.58-5.45%
Q2 2024

May 8, 2024

$9.98M$11.68M+17.07%-$0.34-$0.55-61.76%
Q1 2024

Mar 7, 2024

$8.90M$14.03M+57.62%-$0.60-$0.33+45.00%
Q4 2023

Nov 1, 2023

$8.71M$15.20M+74.54%-$0.62-$0.33+46.77%
Q3 2023

Aug 2, 2023

$51.92M$9.11M-82.46%$0.41-$0.61-248.78%
Q2 2023

May 3, 2023

$7.43M$7.68M+3.41%-$0.65-$0.56+13.85%
Q1 2023

Mar 2, 2023

$10.40M$10.53M+1.25%-$0.63-$0.61+3.17%
Q4 2022

Nov 2, 2022

$10.93M$10.01M-8.37%-$0.70-$0.49+30.00%
Q3 2022

Aug 3, 2022

$10.86M$11.56M+6.45%-$0.57-$0.52+8.77%
Q2 2022

May 4, 2022

$9.89M$9.29M-6.00%-$0.50-$0.52-4.00%
Q1 2022

Mar 3, 2022

$9.79M$11.54M+17.90%-$0.50-$0.59-18.00%
Q4 2021

Nov 3, 2021

$9.84M$9.06M-7.94%-$0.47-$0.58-23.40%
Q3 2021

Aug 4, 2021

$9.01M$9.01M+0.00%-$0.45-$0.35+22.22%
Q2 2021

May 5, 2021

$8.06M$7.32M-9.14%-$0.53-$0.50+5.66%
Q1 2021

Mar 4, 2021

$15.73M$7.13M-54.67%$0.45-$1.01-324.44%
Q4 2020

Nov 5, 2020

$4.08M$15.70M+284.30%-$0.10-$0.30-200.00%
Q3 2020

Aug 5, 2020

$4.12M$4.12M+0.00%-$1.10-$1.00+9.09%
Q2 2020

May 6, 2020

$6.81M$7.49M+10.00%-$1.00-$1.10-10.00%
Q1 2020

Mar 5, 2020

$10.36M$8.63M-16.67%-$1.20-$0.90+25.00%
Q4 2019

Nov 7, 2019

$2.34M$2.51M+7.14%-$1.40-$1.40+0.00%
Q3 2019

Aug 7, 2019

$7.87M$7.21M-8.33%-$1.30-$1.10+15.38%
Q2 2019

May 8, 2019

$1.41M$2.01M+42.86%-$1.30-$1.60-23.08%
Q1 2019

Mar 14, 2019

$2.85M$2.44M-14.29%-$1.40-$1.20+14.29%
Q4 2018

Nov 6, 2018

$165.68K$486.00K+193.33%-$1.30-$1.90-46.15%
Q3 2018

Sep 12, 2018

$127.74K$715.00K+459.73%-$0.90-$1.90-111.11%
Q2 2018

May 8, 2018

$806.00K$928.00K+15.14%-$1.30-$1.50-15.38%
Q1 2018

Feb 7, 2018

$1.07M$933.00K-13.05%-$0.15-$0.13+13.33%
Q4 2017

Nov 7, 2017

$390.00K$385.00K-1.28%-$1.50-$1.50+0.00%
Q3 2017

Sep 11, 2017

$656.25K$701.00K+6.82%-$1.50-$1.60-6.67%
Q2 2017

May 4, 2017

$590.00K$590.00K+0.00%-$1.50-$1.50+0.00%
Q1 2017

Feb 7, 2017

$10.16M$5.97M-41.24%-$1.83-$0.02+98.93%
Q4 2016

Nov 7, 2016

$253.33K$277.00K+9.34%-$1.90-$2.10-10.53%
Q3 2016

Sep 12, 2016

$189.47K$304.00K+60.45%-$1.25-$1.90-52.00%
Q2 2016

May 5, 2016

$405.33K$324.00K-20.07%-$1.95-$1.50+23.08%
Q1 2016

Feb 8, 2016

$441.67K$526.00K+19.09%-$1.50-$1.80-20.00%
Q4 2015

Nov 5, 2015

$387.06K$466.00K+20.40%-$1.45-$1.70-17.24%
Q3 2015

Sep 9, 2015

$313.53K$409.00K+30.45%-$1.35-$1.70-25.93%
Q2 2015

May 8, 2015

$252.35K$328.00K+29.98%-$1.27-$1.70-33.86%
Q1 2015

Feb 5, 2015

$482.86K$521.00K+7.90%-$1.30-$1.40-7.69%
Q4 2014

Nov 7, 2014

$4.53M$25.31M+458.27%-$1.20$6.70+658.33%
Q3 2014

Sep 9, 2014

$290.00K$292.00K+0.69%-$1.45-$1.40+3.45%
Q2 2014

May 13, 2014

$3.73M$1.99M-46.61%-$1.50-$0.80+46.67%
Q1 2014

Feb 7, 2014

$590.00K$592.00K+0.34%-$1.30-$1.30+0.00%
Q4 2013

Nov 12, 2013

$557.14K$597.00K+7.15%-$1.30-$1.40-7.69%
Q3 2013

Sep 25, 2013

$345.88K$492.00K+42.25%-$1.20-$1.70-41.67%
Q2 2013

May 13, 2013

$552.50K$513.00K-7.15%-$1.30-$1.20+7.69%
Q1 2013

Feb 6, 2013

$697.27K$585.00K-16.10%-$1.30-$1.10+15.38%
Q4 2012

Nov 8, 2012

$500.00K$553.00K+10.60%-$1.00-$1.10-10.00%
Q3 2012

Sep 24, 2012

$1.21M$699.00K-42.19%-$1.90-$1.10+42.11%
Q2 2012

May 9, 2012

$706.15K$538.00K-23.81%-$1.75-$1.30+25.71%
Q1 2012

Feb 8, 2012

$823.85K$630.00K-23.53%-$1.75-$1.30+25.71%
Q4 2011

Nov 7, 2011

$2.90M$1.66M-42.89%-$2.10-$1.20+42.86%
Q3 2011

Sep 12, 2011

$66.96M$3.71M-94.45%-$1.80-$0.10+94.44%
Q2 2011

May 10, 2011

$581.54K$360.00K-38.10%-$2.15-$1.30+39.53%
Q1 2011

Feb 9, 2011

$1.23M$414.00K-66.34%$4.50-$1.50-133.33%
Q4 2010

Nov 9, 2010

$476.00K-$1.68
Q4 2010

Nov 5, 2010

$395.29K$15.72M+3877.29%-$1.45-$1.70-17.24%
Q2 2010

May 13, 2010

$515.00K-$1.46
Q2 2010

May 12, 2010

$3.43M-$1.90-$0.01+99.31%
Q4 2009

Nov 13, 2009

$3.38M-$0.87
Q3 2009

Sep 25, 2009

$3.22M-$0.29
Q2 2009

May 13, 2009

$3.16M-$0.35
Q1 2009

Feb 11, 2009

$2.97M-$0.48
Q4 2008

Nov 12, 2008

$2.81M-$0.26
Q3 2008

Sep 26, 2008

$2.70M-$35.00
Q2 2008

May 12, 2008

$542.00K-$3.01
Q1 2008

Feb 11, 2008

$128.00K-$3.17
Q4 2007

Nov 14, 2007

$103.00K-$0.44
Q4 2007

Oct 1, 2007

$455.00K-$9.50
Q1 2007

Mar 31, 2007

$65.00K-$1.94
Q4 2006

Dec 31, 2006

$837.19K-$39.87
Q4 2006

Dec 8, 2006

$409.72K-$4.05
Q3 2006

Sep 30, 2006

$790.44K$37.59
Q3 2006

Aug 14, 2006

$351.90K-$5.81
Q3 2006

Jul 31, 2006

$375.12K-$6.20
Q1 2006

Jan 18, 2006

$148.43K-$1.44
Q4 2005

Dec 22, 2005

$670.71K-$5.96
Q1 2005

Mar 31, 2005

$160.37K-$1.37
Q4 2004

Dec 31, 2004

$161.82K-$1.38
Q3 2004

Sep 30, 2004

$150.75K-$1.29
Q2 2004

Jun 30, 2004

$46.64K-$0.25
Q1 2004

Mar 31, 2004

$72.86K-$0.57
Q4 2003

Dec 31, 2003

$71.79K-$0.56
Q3 2003

Sep 30, 2003

$64.89K-$0.51
Q2 2003

Jun 30, 2003

$24.16K-$0.33
Q1 2003

Mar 31, 2003

$16.73K-$0.45
Q4 2002

Dec 31, 2002

$15.52K-$0.42
Q3 2002

Sep 30, 2002

$15.02K-$0.41